Robert A. Orlando
University of California, Irvine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert A. Orlando.
Cancer | 1976
Russell Hilf; William D. Rector; Robert A. Orlando
Normal and abnormal breast samples of women were analyzed for multiple molecular forms of lactate dehydrogenase and glucose 6‐phosphate dehydrogenase, using acrylamide disc gel electrophoresis and specific enzyme staining techniques for separation and quantitation. Infiltrating ductal carcinomas demonstrated a significant increase (three‐to six‐fold) in the proportion of LDH‐5 compared to samples of normal breast, fibrocystic disease and fibroadenoma, indicative of a shift toward the muscle‐type lactate dehydrogenase in neoplasia. For glucose 6‐phosphate dehydrogenase, carcinomas were found to contain increased proportions of the fastest migrating species, G6PD‐I. Total enzyme activity/mg DNA was elevated in neoplastic tissues. Little or no alteration in isoenzyme profiles could be related to menopausal status of the patient.
Experimental Biology and Medicine | 1969
Russell Hilf; Harold Goldenberg; Robert A. Orlando; Francis L. Archer
Summary Human infiltrating ductal carcinoma of the breast, fibrocystic disease of the breast, and normal human mammary tissues were assayed for their concentration of nucleic acid, lipids, and 11 selected enzymes involved in carbohydrate, lipid, and amino acid metabolism. Comparing infiltrating ductal carcinomas to normal mammary tissue, striking elevations (p <0.001) were seen in pyruvate kinase (100-fold), glucose-6-phosphate, isocitrate and malate dehydrogenases (10-15-fold), free fatty acids and cholesterol (2-3-fold). The RNA/DNA ratios in the carcinomas were unchanged but triglycerides and α-glycerolphosphate dehydrogenase were reduced. Also studied were samples from eight cases of fibrocystic disease, a common nonmalignant proliferative disease of the human breast. Ranking the levels of nucleic acids and lipids and the activities of the enzymes in the tissues studied clearly showed that normal ≦ fibrocystic disease ≦ infiltrating ductal carcinoma. No significant differences in the biochemical characteristics of the carcinomas were found relative to the size of the lesion or to the menopausal state of the patient. These data on infiltrating ductal carcinomas closely resemble the data obtained from single dose 7,12-dimethylbenz [a] anthracene-induced rat mammary carcinomas, suggesting that the latter experimental tumor may represent a valid metabolic model of human breast cancer.
Enzymologia biologica et clinica | 1970
Russell Hilf; Harold Goldenberg; Carlton Bell; Inge Michel; Robert A. Orlando; Francis L. Archer
SummaryIn order to establish valid experimental systems for the study of breast cancer, an examination of the biochemical and morphologic characteristics of transplantable and carcinogen-induced mamma
Archives of Biochemistry and Biophysics | 1986
Julie-Lani Ngo; Robert A. Orlando; Kenneth H. Ibsen
Total protein content of P-815 mastocytoma cells decreases and then increases in response to initiation of a new growth cycle. As the level increases, the rate of synthesis declines. Both events occur prior to any decrease in the rate of cellular proliferation. These temporal relationships indicate that the rate of protein synthesis reflects the intracellular concentration of protein rather than the cellular growth rate, as has been hypothesized. Pyruvate kinase protein metabolism differs from that of total protein in three ways: (a) accumulation does not stop, (b) the rate of synthesis does not decrease, and (c) only the rate of pyruvate kinase degradation is altered by a factor present in conditioned media. These observations suggest that there are specific mechanisms regulating pyruvate kinase at a post-transcriptional level.
Cancer Research | 1972
James L. Wittliff; Russell Hilf; William F. Brooks; Edwin D. Savlov; Thomas C. Hall; Robert A. Orlando
Cancer Research | 1973
Russell Hilf; James L. Wittliff; William D. Rector; Edwin D. Savlov; Thomas C. Hall; Robert A. Orlando
Cancer Research | 1968
Francis L. Archer; Robert A. Orlando
Cancer Research | 1982
Kenneth H. Ibsen; Robert A. Orlando; Kirk N. Garratt; Ana M. Hernandez; Stephanie Giorlando; Gloria Nungaray
Cancer Research | 1970
Russell Hilf; Harold Goldenberg; Inge Michel; Robert A. Orlando; Francis L. Archer
Journal of Cellular Physiology | 1987
Daniel J. Knauer; Robert A. Orlando; Dorrie Rosenblatt